LamivudineReverse Transcriptase InhibitorsHepatitis B, ChronicOrganophosphonatesHepatitis B virusAntiviral AgentsHepatitis B e AntigensAdenineAnti-HIV AgentsDrug Resistance, ViralZidovudineStavudineDrug Therapy, CombinationHepatitis BDideoxynucleosidesHIV InfectionsNevirapineBenzoxazinesDNA, ViralTreatment OutcomeAlanine TransaminaseViral LoadHepatitis B Surface AntigensHIV-1IndinavirDidanosinePyrimidinonesDrug Administration ScheduleAntiretroviral Therapy, Highly ActiveOxazinesTreatment FailureNucleosidesDrug Resistance, Multiple, ViralHepatitis B AntibodiesRitonavirNelfinavirGene Products, polLopinavirCD4 Lymphocyte CountRecurrenceZalcitabineGuanineMutationHIV Protease InhibitorsInterferon-alphaHIV Reverse TranscriptaseLiver TransplantationDideoxynucleotidesRNA, ViralInfectious Disease Transmission, VerticalHepatitis B Core AntigensLiver CirrhosisVirus ActivationDouble-Blind MethodImmunoglobulinsAntineoplastic Combined Chemotherapy ProtocolsCytidine TriphosphateRetrospective StudiesArabinofuranosyluracilArea Under CurveAnti-Retroviral AgentsDrug CombinationsTherapeutic EquivalencyTime Factors2-AminopurineDeoxycytidineDrug Resistance, MicrobialPolyethylene GlycolsProspective StudiesAdministration, OralGenotypeFollow-Up Studies